EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

1,2,3‐Triazole‐Linked Chalcones as Privileged Scaffolds in Anticancer Agents

Sumeyya Koldas, Guler Yagiz Erdemir iD, Ahsen Kilic, Neslisah Barlak, Omer Faruk Karatas, Aliye Altundas

Archiv der Pharmazie · 2026-06 · 359 (6)

DOI: 10.1002/ardp.70291 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Archiv der Pharmazie, online erschienen am 07.07.2026. Verfasst von Sumeyya Koldas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Gazi University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Antineoplastic Agents, Chalcones, Triazoles. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gazi Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A new series of extended‐functionality triazole‐substituted chalcone derivatives was synthesized, and their in vitro anti‐proliferative and cytotoxic profiles were evaluated using cancer and non‐cancer cell models. First, all compounds were screened in the FaDu head and neck squamous cell carcinoma cell line to identify the most active candidates with comparatively lower IC 50 values. Compounds 6c , 6e , and 6f reduced FaDu cell viability to 42.62 ± 12.21%, 34.49 ± 4.99%, and 31.13 ± 4.76% of control, respectively. These three compounds also decreased viability of CaCo‐2 human colon cancer cells and A549 human lung adenocarcinoma cells, showing micromolar‐range activity (IC 50 < 50 µM) across cancer cell lines of different origins. To obtain a preliminary indication of selectivity, we additionally tested a non‐cancer, immortalized prostate epithelial cell line (PNT1a). In this model, 6c / 6e / 6f displayed relatively lower cytotoxicity than in cancer cells, suggesting a preliminary selectivity window within the tested assay framework. Among them, 6f the most active compound in our series—significantly reduced colony formation, comparable to paclitaxel. In apoptosis‐related assessments, 6f increased apoptosis‐associated readouts in cancer cells relative to control, although further confirmation is needed with additional orthogonal assays. Overall, our results identify 6c , 6e , and especially 6f as moderately active lead compounds for further optimization of triazole‐chalcone hybrids and support continued structure–activity‐guided development to improve potency and selectivity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsChalconesTriazolesHumansStructure-Activity RelationshipCell SurvivalCell ProliferationApoptosisMolecular StructureDrug Screening Assays, AntitumorDose-Response Relationship, DrugCaco-2 CellsCell Line, TumorInhibitory Concentration 50A549 Cells

Stichwörter der Autor:innen

1,2,3‐triazolediesterA549CaCo‐2cancerchalconescytotoxicity

Substanzen

Antineoplastic AgentsChalconesTriazoles

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Science, Gazi University, Ankara, Türkiye.
  • Department of Chemistry, Graduate School of Natural and Applied Sciences, Gazi University, Ankara, Türkiye.
  • Department of Molecular Biology and Genetics, Erzurum Technical University, Erzurum, Türkiye.
  • Department of Molecular Cancer Biology Laboratory, High Technology Application and Research Center, Erzurum Technical University, Erzurum, Türkiye.

ORCID-Profile: Guler Yagiz Erdemir

Förderung

  • Gazi Üniversitesi

Zitieren

APA

Koldas, S., Erdemir, G. Y., Kilic, A., Barlak, N., Karatas, O. F., & Altundas, A. (2026). 1,2,3‐Triazole‐Linked Chalcones as Privileged Scaffolds in Anticancer Agents. Archiv der Pharmazie, 359(6). https://doi.org/10.1002/ardp.70291

Vancouver

Koldas S, Erdemir GY, Kilic A, Barlak N, Karatas OF, Altundas A. 1,2,3‐Triazole‐Linked Chalcones as Privileged Scaffolds in Anticancer Agents. Archiv der Pharmazie. 2026;359(6). doi:10.1002/ardp.70291

BibTeX
@article{Koldas2026,
  author = {Koldas, Sumeyya and Erdemir, Guler Yagiz and Kilic, Ahsen and Barlak, Neslisah and Karatas, Omer Faruk and Altundas, Aliye},
  title = {1,2,3‐Triazole‐Linked Chalcones as Privileged Scaffolds in Anticancer Agents},
  journal = {Archiv der Pharmazie},
  year = {2026},
  volume = {359},
  number = {6},
  doi = {10.1002/ardp.70291}
}
Kostenlos starten →